1. A Phase III, randomized, double-blind, placebo-controlled, multicenter study of fruquintinib in Chinese patients with advanced nonsquamous non-small-cell lung cancer – The FALUCA study. (August 2020) Authors: Lu, Shun; Chen, Gongyan; Sun, Yuping; Sun, Sanyuan; Chang, Jianhua; Yao, Yu; Chen, Zhendong; Ye, Feng; Lu, Junguo; Shi, Jianhua; He, Jianxing; Liu, Xiaoqing; Zhang, Yiping; Liu, Zhihua; Fang, Jian; Cheng, Ying; Hu, Chunhong; Mao, Weidong; Hu, Yanping; Gong, Youling Journal: Lung cancer Issue: Volume 146(2020) Page Start: 252 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Ag2O/sodium alginate supramolecular hydrogel as a film photocatalyst for removal of organic dyes in wastewater. Issue 25 (7th March 2017) Authors: Ma, Yuhua; Wang, Jiajia; Xu, Shimei; Zheng, Zhendong; Du, Juan; Feng, Shun; Wang, Jide Journal: RSC advances Issue: Volume 7:Issue 25(2017) Page Start: 15077 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Application of a parallel spectral–spatial convolution neural network in object-oriented remote sensing land use classification. Issue 4 (3rd April 2018) Authors: Cui, Wei; Zheng, Zhendong; Zhou, Qi; Huang, Jiejun; Yuan, Yanbin Journal: Remote sensing letters Issue: Volume 9:Issue 4(2018) Page Start: 334 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Comparison of efficacy and safety of ripertamab (SCT400) versus rituximab (Mabthera®) in combination with CHOP in patients with previously untreated CD20‐positive diffuse large B‐cell lymphoma: A randomized, single‐blind, phase III clinical trial. Issue 5 (12th August 2022) Authors: Shi, Yuankai; Zhang, Qingyuan; Hong, Xiaonan; Wang, Zhen; Gao, Yuhuan; Zou, Liqun; Cen, Hong; Gui, Lin; Li, Yufu; Feng, Jifeng; Wang, Zhao; Zhang, Mingzhi; Jin, Chuan; Zhang, Weihua; Hu, Jianda; Zheng, Chengyun; Zheng, Zhendong; Zhang, Liling; Chen, Shaoshui; Huang, Yunhong Journal: Hematological oncology Issue: Volume 40:Issue 5(2022) Page Start: 930 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Disulfiram/Copper induces antitumor activity against gastric cancer via the ROS/MAPK and NPL4 pathways. Issue 3 (1st March 2022) Authors: Liu, Yao; Guan, Xin; Wang, Meiling; Wang, Naixue; Chen, Yutong; Li, Baolei; Xu, Zhuxuan; Fu, Fangwei; Zheng, Zhendong; Du, Cheng Journal: Bioengineered Issue: Volume 13:Issue 3(2022) Page Start: 6579 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Disulfiram/Copper induces antitumor activity against gastric cancer via the ROS/MAPK and NPL4 pathways. Issue 3 (1st March 2022) Authors: Liu, Yao; Guan, Xin; Wang, Meiling; Wang, Naixue; Chen, Yutong; Li, Baolei; Xu, Zhuxuan; Fu, Fangwei; Du, Cheng; Zheng, Zhendong Journal: Bioengineered Issue: Volume 13:Issue 3(2022) Page Start: 6579 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Donafenib Versus Sorafenib in First-Line Treatment of Unresectable or Metastatic Hepatocellular Carcinoma: A Randomized, Open-Label, Parallel-Controlled Phase II-III Trial. Issue 27 (20th September 2021) Authors: Qin, Shukui; Bi, Feng; Gu, Shanzhi; Bai, Yuxian; Chen, Zhendong; Wang, Zishu; Ying, Jieer; Lu, Yinying; Meng, Zhiqiang; Pan, Hongming; Yang, Ping; Zhang, Helong; Chen, Xi; Xu, Aibing; Cui, Chengxu; Zhu, Bo; Wu, Jian; Xin, Xiaoli; Wang, Jufeng; Shan, Jinlu Journal: Journal of clinical oncology Issue: Volume 39:Issue 27(2021) Page Start: 3002 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Efficacy, safety, and biomarker analysis of ensartinib in crizotinib-resistant, ALK-positive non-small-cell lung cancer: a multicentre, phase 2 trial. Issue 1 (January 2020) Authors: Yang, Yunpeng; Zhou, Jianya; Zhou, Jianying; Feng, Jifeng; Zhuang, Wu; Chen, Jianhua; Zhao, Jun; Zhong, Wei; Zhao, Yanqiu; Zhang, Yiping; Song, Yong; Hu, Yi; Yu, Zhuang; Gong, Youling; Chen, Yuan; Ye, Feng; Zhang, Shucai; Cao, Lejie; Fan, Yun; Wu, Gang Journal: Lancet Issue: Volume 8:Issue 1(2020) Page Start: 45 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Real‐world EGFR testing in patients with stage IIIB/IV non‐small‐cell lung cancer in North China: A multicenter, non‐interventional study. Issue 11 (25th September 2018) Authors: Cheng, Ying; Wang, Yan; Zhao, Jun; Liu, Yunpeng; Gao, Hongjun; Ma, Kewei; Zhang, Shucai; Xin, Hua; Liu, Jiwei; Han, Chengbo; Zhu, Zhitu; Wang, Yan; Chen, Jun; Wen, Fugang; Li, Junling; Zhang, Jie; Zheng, Zhendong; Dai, Zhaoxia; Piao, Hongmei; Li, Xiaoling Journal: Thoracic cancer Issue: Volume 9:Issue 11(2018) Page Start: 1461 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Successful treatment of advanced pancreatic liposarcoma with apatinib: A case report and literature review. Issue 9 (2nd September 2017) Authors: Han, Tao; Luan, Yuting; Xu, Ying; Yang, Xiaodan; Li, Jing; Liu, Ran; Li, Qing; Zheng, Zhendong Journal: Cancer biology & therapy Issue: Volume 18:Issue 9(2017) Page Start: 635 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗